National Stock Number (NSN) Output Data
NSN:
NIIN:
Item Name:
ATENOLOL TABLETS , USP
Definition:
Reference/Part Number
| Part Number | CAGE | Status | RNCC | RNVC | DAC | RNAAC | MSDS | SADC |
|---|---|---|---|---|---|---|---|---|
| NDC00591-5778-01 | 62051 | A | 3 | 2 | 4 | ZZ | ||
| NDC00591-5778-01 | 1UVZ2 | A | 3 | 2 | 4 | ZZ | ||
| NDC00378-0757-01 | 60895 | A | 5 | 2 | 4 | ZZ | ||
| NDC00093-0753-01 | 80608 | A | 5 | 2 | 4 | ZZ | ||
| NDC00310-0010-11 | 0A273 | A | 3 | 2 | 3 | ZZ | ||
| NDC00781-1507-01 | 0THL4 | A | 3 | 2 | 4 | ZZ | ||
| NDC00310-0101-10 | 04473 | A | 5 | 2 | 4 | ZZ | ||
| NDC53489-0530-01 | 0A539 | A | 5 | 2 | 4 | ZZ | ||
| NDC00093-0753-01 | 3V8D7 | A | 3 | 2 | 4 | ZZ |
CAGE Information
| Code | Company |
|---|---|
| 04473 | ASTRA PHARMACEUTICALS LP |
| 62051 | DANBURY PHARMACAL INC |
| 1UVZ2 | WATSON PHARMACEUTICALS INC. |
| 60895 | MYLAN PHARMACEUTICALS INC |
| 80608 | LEMMON CO |
| 0A273 | ASTRAZENECA LP |
| 0THL4 | SANDOZ INC. |
| 0A539 | MUTUAL PHARMACEUTICAL COMPANY INC. D |
| 3V8D7 | TEVA PHARMACEUTICALS USA INC. DBA GA |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
| MRC | Requirements Statement | Clear Text Reply |
|---|---|---|
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | ATENOLOL TABLETS 100MG 100S BT |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 100.000 MILLIGRAMS ATENOLOL ACTIVE INGREDIENT |